Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 17, Issue 7, 2007, Pages 517-524

  Targher, Giovanni ^a   Bertolini, Lorenzo ^a   Scala, Luca ^a   Cigolini, Massimo ^b   Zenari, Luciano ^a   Falezza, Giancarlo ^a   Arcaro, Guido ^a  

^a Diabetes Unit   (Italy)

^b Ospedale Civile di Arzignano   (Italy)

Author keywords

Insulin resistance; Metabolic syndrome; Non alcoholic fatty liver disease; Vitamin D

Indexed keywords

BIOLOGICAL MARKER; CALCIFEDIOL;

ARTICLE; BLOOD; BODY MASS; CASE CONTROL STUDY; FATTY LIVER; FEMALE; HOSPITALIZATION; HUMAN; LIVER; LIVER FUNCTION TEST; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PATHOLOGY; SEASON;

BIOLOGICAL MARKERS; BODY MASS INDEX; CALCIFEDIOL; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; HUMANS; LIVER; LIVER FUNCTION TESTS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SEASONS; SEVERITY OF ILLNESS INDEX;

EID: 34547485376     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2006.04.002     Document Type: Article

References (35)

1. Holick M.F., and Vitamin D. importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79 (2004) 362-371
2. Mosekilde L. Vitamin D and the elderly. Clin Endocrinol 62 (2005) 265-281
3. Boucher B.J., Mannan N., Noonan K., Hales C.N., and Evans S.J. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 38 (1995) 1239-1245
4. Scragg R., Sowers M., and Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27 (2004) 2813-2818
5. Boucher B.J. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome X?. Br J Nutr 79 (1998) 315-327
6. Ford E.S., Ajani U.A., McGuire L.C., and Liu S. Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care 28 (2005) 1228-1230
7. Chiu K.C., Chu A., Go V.L., and Saad M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79 (2004) 820-825
8. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346 (2002) 1221-1231
9. McCullough A.J. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 8 (2004) 521-533
10. Adams L.A., and Angulo P. Recent concepts in nonalcoholic fatty liver disease. Diabet Med 22 (2005) 1129-1133
11. Targher G., Bertolini L., Poli F., Rodella S., Scala L., Tessari R., et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 54 (2005) 3541-3546
12. Bonora E., Targher G., Alberiche M., Bonadonna R.C., Saggiani F., Zenere B.M., et al. Homeostasis Model Assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23 (2000) 57-63
13. National Cholesterol Education Program. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
14. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., and Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94 (1999) 2467-2474
15. Thomas M.K., Lloyd-Jones D.M., Thadhani R.I., Shaw A.C., Deraska D.J., Kitch B.T., et al. Hypovitaminosis D in medical inpatients. N Engl J Med 338 (1998) 777-783
16. Borissova A.M., Tankova T., Kirilov G., Dakovska L., and Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Intern J Clin Pract 57 (2003) 258-261
17. Mak R.H., and Wong J.H. The vitamin D/parathyroid hormone axis in the pathogenesis of hypertension and insulin resistance in uremia. Min Electr Metab 18 (1992) 156-159
18. Brown A., Dusso A., and Slatopolsky E. Vitamin D. Am J Physiol 277 (1999) F157-F175
19. Barsony J., and Prufer K. Vitamin D receptors and retinoid X receptors interactions in motion. Vitam Horm 65 (2002) 345-376
20. Norman P.E., and Powell J.T. Vitamin D, shedding light on the development of disease in peripheral arteries. Arterioscler Thromb Vasc Biol 25 (2005) 39-46
21. Veldman C., Cantorna M., and DeLuca H. Expression of 1, 25 dihydroxyvitamin D3 receptor in the immune system. Arch Biochem Biophys 374 (2000) 334-338
22. Willheim M., Thien R., Schrattbauer K., Bajna E., Holub M., Gruber R., et al. Regulatory effects of 1alpha, 25 dihydroxyvitamin D3 on the cytokine production of human peripheral blood lymphocytes. J Clin Endocrinol Metab 84 (1999) 3739-3744
23. Timms P.M., Mannan N., Hitman G.A., Noonan K., Mills P.G., Syndercombe-Court D., et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?. Q J Med 95 (2002) 787-796
24. Cigolini M., Iagulli M.P., Miconi V., Galiotto M., Lombardi S., and Targher G. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 29 (2006) 722-724
25. Van den Berghe G., Van Roosbroeck D., Vanhove P., Wouters P.J., De Pourcq L., and Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 88 (2003) 4623-4632
26. McCarty M.F. Secondary hyperparathyroidism promotes the acute phase response-a rationale for supplemental vitamin D in prevention of vascular events in the elderly. Med Hypotheses 64 (2005) 1022-1026
27. Scragg R., Jackson R., Holdaway I., Lim T., and Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 19 (1990) 559-563
28. Doherty T., Tang W., Dascolas S., Watson K.E., Demer L.L., Shavelle R., et al. Ethnic origin and serum levels of 1,25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. Circulation 96 (1997) 1477-1481
29. Watson K.E., Abrolat M.L., Malone L.L., Hoeg J.M., Doherty T., Detrano R., et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96 (1997) 1755-1760
30. Marniemi J., Alanen E., Impivaara O., Seppanen R., Hakala P., Rajala T., et al. Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. Nutr Metab Cardiovasc Dis 15 (2005) 188-197
31. Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., and Holick M.F. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72 (2000) 690-693
32. Bouillon R., Auwerx J., Dekeyser L., Fevery J., Lissens W., and De Moor P. Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis. J Clin Endocrinol Metab 59 (1984) 86-89
33. Duarte M.P., Farias M.L., Coelho H.S., Mendonca L.M., Stabnov L.M., do Carmo Oliveira M., et al. Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol 16 (2001) 1022-1027
34. Levy C., and Lindor K.D. Management of osteoporosis, fat-soluble vitamin deficiencies, and hyperlipidemia in primary biliary cirrhosis. Clin Liver Dis 7 (2003) 901-910
35. Moreira R.O., Duarte M.P., and Farias M.L. Disturbances of calcium-PTH-vitamin D axis in chronic liver diseases. Arq Bras Endocrinol Metabol 48 (2004) 443-450